🇺🇸 FDA
Patent

US 10799475

Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth

granted A61KA61K31/135A61K31/216

Quick answer

US patent 10799475 (Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth) held by Northwestern University expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/135, A61K31/216, A61K31/222, A61K31/396